About Us
At Atombeat, we are a passionate collective of scientists and innovators united by a singular goal: democratizing computational tools for drug discovery. Born from diverse scientific backgrounds, our small but driven team develops and harnesses cutting-edge AI and physics-based modeling to empower researchers globally.
We build rigorously validated platforms, designed to tackle challenging targets and accelerate the discovery of life-changing therapies. Every tool we create undergoes meticulous testing, ensuring state-of-the-art performance you can trust.
True to our commitment to open science, we openly share findings and contribute to the community, because progress thrives when knowledge has no boundaries. Together, we’re redefining what’s possible—one discovery at a time
Product Timeline
Launched Hermite® Computational Drug Discovery Platform.
Launched Uni-FEP module, enabling protein-ligand affinity computation at chemical accuracy.
Launched RiD module, addressing the sampling challenge in modeling large biomolecules. The work is published on Nature Computational Science.
Announced RiDYMO™ platform and latest advancement in targing c-Myc.
Published Uni-Mol Docking v2, which was benchmarked against AlphaFold 3 as previous SOTA.
Launched Uni-Dock v1.1 which is capable of screening 100 million ligands in just 8 hours and is featured on NVIDIA's BioNeMo platform.
RiDYMO™ platform successfully designs cyclic peptide targeting β-catenin, breakingthrough the limitation of natural amino acid.
Revamped Uni-FEP, which boasted enhanced performance and expanded functionalities.
Meet Our Team
Browse Careers
We're currently looking for talented people to join our team. Please check the below job listing to see if it's for you!
Our mission is to democratize computational drug discovery tools and empower researchers and organizations worldwide.